Adalta Capital Management LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,045 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Adalta Capital Management LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$928
+25.7%
24,460
+52.0%
0.63%
+28.2%
Q2 2023$738
+10.5%
16,090
-1.7%
0.49%
+5.6%
Q1 2023$668
-20.6%
16,365
-0.3%
0.47%
-21.2%
Q4 2022$841
-99.9%
16,415
-1.4%
0.59%
-8.3%
Q3 2022$901,000
-16.5%
16,640
-0.4%
0.65%
-7.7%
Q2 2022$1,079,000
-17.1%
16,7150.0%0.70%
+8.0%
Q1 2022$1,301,000
-9.6%
16,7150.0%0.65%
-2.3%
Q4 2021$1,439,000
+6.7%
16,7150.0%0.66%
-11.1%
Q3 2021$1,349,000
-1.3%
16,715
-1.3%
0.75%
+0.4%
Q2 2021$1,367,000
-4.6%
16,9400.0%0.74%
-10.0%
Q1 2021$1,433,000
+5.1%
16,9400.0%0.83%
-3.8%
Q4 2020$1,363,000
-0.1%
16,940
+0.1%
0.86%
-13.6%
Q3 2020$1,364,000
-6.6%
16,9150.0%1.00%
-14.4%
Q2 2020$1,460,000
+6.0%
16,9150.0%1.16%
-7.0%
Q1 2020$1,377,000
-3.6%
16,915
-0.7%
1.25%
+39.2%
Q4 2019$1,428,000
-4.6%
17,040
-0.2%
0.90%
-9.5%
Q3 2019$1,497,000
+14.1%
17,075
+6.9%
0.99%
+15.1%
Q2 2019$1,312,000
+0.6%
15,975
-0.2%
0.86%
-12.6%
Q1 2019$1,304,000
+23.5%
16,0000.0%0.99%0.0%
Q4 2018$1,056,000
-16.7%
16,000
-2.4%
0.99%
+9.0%
Q3 2018$1,268,000
+4.4%
16,4000.0%0.90%
+5.5%
Q2 2018$1,214,000
+12.2%
16,400
-1.2%
0.86%
+3.9%
Q1 2018$1,082,000
-8.4%
16,600
-8.9%
0.83%
-8.1%
Q4 2017$1,181,000
-14.2%
18,225
-16.7%
0.90%
-19.9%
Q3 2017$1,376,000
+2.5%
21,875
-1.1%
1.12%
+3.6%
Q2 2017$1,343,000
+11.3%
22,125
-4.7%
1.08%
+6.2%
Q1 2017$1,207,00023,2251.02%
Other shareholders
BAXTER INTL INC shareholders Q4 2017
NameSharesValueWeighting ↓
Tavio Capital LLC 68,405$5,890,0007.81%
Iron Triangle Partners LP 330,000$28,413,0007.16%
Veritas Asset Management LLP 8,942,428$769,943,0005.64%
TSFG, LLC 93,405$8,042,0005.31%
GENERATION INVESTMENT MANAGEMENT LLP 10,606,094$913,185,0005.27%
Third Point 4,000,000$344,400,0004.72%
Avidity Partners Management LP 800,900$68,957,0004.42%
Palmer Knight Co 62,275$5,362,0004.17%
Eos Focused Equity Management, L.P. 36,786$3,167,0003.70%
Dundas Partners LLP 196,133$16,887,0003.69%
View complete list of BAXTER INTL INC shareholders